Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Portfolio Pulse from Chris Katje
Benzinga's Stock Whisper Index has highlighted five stocks that warrant attention for the week of Oct. 20, 2023. These include NuZee Inc (NASDAQ:NUZE), which saw a significant drop in share price after announcing a public offering; Bridger Aerospace Group Holdings (NASDAQ:BAER), which also saw a drop in shares after a public offering announcement; Spectral AI (NASDAQ:MDAI), which saw shares rise after its medical device received FDA classification; SeaStar Medical Holding Corporation (NASDAQ:ICU), which saw shares rise after receiving FDA Breakthrough Device Designation; and Nokia Corporation (NYSE:NOK), which saw shares fall after reporting a drop in Q3 sales.
October 20, 2023 | 2:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bridger Aerospace Group Holdings announced a public offering of $70 million, leading to a drop in its share price.
The announcement of a public offering has led to a drop in Bridger Aerospace's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Nokia Corporation saw its shares fall after reporting a 20% year-over-year drop in Q3 sales.
The reported drop in Q3 sales has led to a fall in Nokia's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
NuZee Inc announced a public offering of 425,000 shares at a price of $3 each, causing the stock price to fall over 40% in the last five days.
The announcement of a public offering at a price below the current trading price has led to a significant drop in NuZee's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SeaStar Medical Holding Corporation saw its shares rise after it received FDA Breakthrough Device Designation for its Selective Cytopherectic Device.
The FDA Breakthrough Device Designation for SeaStar Medical's device has led to a rise in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Spectral AI saw its shares rise after its DeepView SnapShot Wound Imaging System received Class 1 medical device classification with the FDA.
The FDA classification of Spectral AI's medical device has led to a rise in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100